Endoscopic findings in uninvestigated dyspepsia

Carregando...
Imagem de Miniatura
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Citação
BMC GASTROENTEROLOGY, v.14, article ID 19, 7p, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: It is important to know the causes of dyspepsia to establish the therapeutic approach. Dyspepsia is a frequent syndrome in our country, where there are restrictions to endoscopy and high prevalence of Helicobacter pylori (H. pylori) infection. This study aimed to assess the endoscopic findings of the syndrome, in an outpatient screening clinic of a tertiary hospital in Sao Paulo. Methods: Outpatients with uninvestigated dyspepsia, according to Rome III criteria, answered a dyspepsia questionnaire and underwent esophagogastroduodenoscopy. The Rapid Urease Test was applied to fragments of the antral mucosa and epidemiological data were collected from the studied population. Organic dyspepsia findings were analyzed with different variables to verify statistically significant associations. Results: Three hundred and six patients were included and 282 were analyzed in the study. The mean age was 44 years and women comprised 65% of the sample. Forty-five percent of the patients reported alarm symptoms. Functional dyspepsia was found in 66% of the patients (20% with normal endoscopy results and 46% with gastritis), 18% had GERD and 13% had ulcers (duodenal in 9% and gastric in 4%). Four cases of gastric adenocarcinoma were identified (1.4%), one without alarm characteristics, 1 case of adenocarcinoma of the distal esophagus and 1 case of gastric lymphoma. The prevalence of H. pylori was 54% and infection, age and smoking status were associated with organic dyspepsia. The age of 48 years was indicative of alarm signs. Conclusions: The endoscopic diagnosis of uninvestigated dyspepsia in our setting showed a predominance of functional disease, whereas cancer was an uncommon finding, despite the high prevalence of H. pylori. Organic dyspepsia was associated with infection, age and smoking status.
Palavras-chave
Dyspepsia findings, Esophagitis, Gastric cancer, Peptic ulcer
Referências
  1. Barkun AN, 2010, CAN J GASTROENTEROL, V24, P489
  2. BYTZER P, 1994, LANCET, V343, P811, DOI 10.1016/S0140-6736(94)92023-0
  3. de Oliveira SA, 2006, REV SAUDE PUBL, V40, P420, DOI 10.1590/S0034-89102006000300009
  4. DominguezBello MG, 1997, DIAGN MICR INFEC DIS, V28, P149, DOI 10.1016/S0732-8893(97)00041-2
  5. Erichsen R, 2012, CLIN GASTROENTEROL H, V10, P475, DOI 10.1016/j.cgh.2011.12.038
  6. Felga G, 2010, J INFECT DEV COUNTR, V4, P712, DOI 10.3855/jidc.911
  7. Ford AC, 2010, CLIN GASTROENTEROL H, V8, P830, DOI 10.1016/j.cgh.2010.05.031
  8. Ghoshal UC, 2011, J NEUROGASTROENTEROL, V17, P235, DOI 10.5056/jnm.2011.17.3.235
  9. Hsu YC, 2012, DIGEST LIVER DIS, V44, P218, DOI 10.1016/j.dld.2011.10.012
  10. Hungin APS, 2001, DIGEST DIS, V19, P219, DOI 10.1159/000050683
  11. JONES RH, 1990, GUT, V31, P401, DOI 10.1136/gut.31.4.401
  12. Khademi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039173
  13. Koch P, 2001, J CLIN ONCOL, V19, P3861
  14. Maconi G, 2009, EUR J GASTROEN HEPAT, V21, P297, DOI 10.1097/MEG.0b013e3283069db0
  15. Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084
  16. Marques Sergio B., 2011, Arquivos de Gastroenterologia, V48, P171, DOI 10.1590/S0004-28032011000300003
  17. Mazzoleni LE, 2011, ARCH INTERN MED, V171, P1929, DOI 10.1001/archinternmed.2011.533
  18. Meineche-Schmidt V, 2002, SCAND J GASTROENTERO, V37, P999, DOI 10.1080/003655202320378167
  19. Milosavljevic T, 2011, DIGEST DIS, V29, P491, DOI 10.1159/000331517
  20. Moayyedi P, 1998, ALIMENT PHARM THERAP, V12, P1257
  21. Muller Leandro Bizarro, 2007, Arquivos de Gastroenterologia, V44, P93, DOI 10.1590/S0004-28032007000200002
  22. Olafsdottir LB, 2012, DIGEST LIVER DIS, V44, P211, DOI 10.1016/j.dld.2011.10.009
  23. Penston JG, 1996, ALIMENT PHARM THERAP, V10, P83
  24. Rodrigues Maria N, 2005, Braz J Infect Dis, V9, P405, DOI 10.1590/S1413-86702005000500008
  25. Rolff HC, 2011, DAN MED BULL, V58
  26. Sander GB, 2011, VALUE HEALTH, V14, pS126, DOI 10.1016/j.jval.2011.05.021
  27. Santos IS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-118
  28. Silva FM, 2010, HELICOBACTER, V15, P46, DOI 10.1111/j.1523-5378.2009.00734.x
  29. Sobieraj DM, 2011, AM J MANAG CARE, V17, P449
  30. Souto FJD, 1998, MEM I OSWALDO CRUZ, V93, P171
  31. Spiegel BMR, 2009, ALIMENT PHARM THER, V29, P871, DOI 10.1111/j.1365-2036.2009.03935.x
  32. Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059
  33. TALLEY NJ, 1992, GASTROENTEROLOGY, V102, P1259
  34. Talley Nicholas J, 2005, Gastroenterology, V129, P1756, DOI 10.1053/j.gastro.2005.09.020
  35. Vakil N, 2006, GASTROENTEROLOGY, V131, P390, DOI 10.1053/j.gastro.2006.04.029
  36. Xinias Ioannis, 2013, Pediatr Rep, V5, pe3, DOI 10.4081/pr.2013.e3
  37. Zaterka S, 2007, HELICOBACTER, V12, P82, DOI 10.1111/j.1523-5378.2007.00474.x